$2.06 -0.57 (%) NeoStem Inc - NASDAQ

May. 28, 2015 | 04:00 PM

Partner Headlines

  1. NeoStem's Lead Immuno-Oncology Product Candidate, NBS20, Receives ATMP Classification From the European Medicines Agency

    Benzinga | Apr. 27, 2015 | 07:30AM EST
  2. NeoStem Announces Expanded Cell Therapy Manufacturing Relationship With Kite Pharma

    Benzinga | Apr. 20, 2015 | 07:30AM EST
  3. NeoStem Receives Drug Manufacture License For Irvine Facility

    Benzinga | Jan. 20, 2015 | 07:30AM EST
  4. "New To The Street"Announces Nationwide Broadcast

    GuruFocus | Dec. 3, 2014 | 11:02AM EST
  5. Morning Market Losers

    Benzinga | Nov. 18, 2014 | 09:52AM EST
  6. Increase Company Value Through Mergers, Acquisitions

    IBD | Jul. 14, 2014 | 13:46PM EST
  7. Events Scheduled for Week of Jun 23rd to Jun 27th, 2014

    Benzinga | Jun. 23, 2014 | 18:25PM EST
  8. US Stock Futures Flat; Citigroup Earnings In Focus

    Benzinga | Apr. 14, 2014 | 07:43AM EST
  9. NeoStem Announces New US and European Patent Allowances

    Benzinga | Jan. 6, 2014 | 07:31AM EST
  10. ImmunoCellular Therapeutics Expands Manufacturing Relationship with Neostem's Progenitor Cell Therapy

    Benzinga | Dec. 3, 2013 | 06:03AM EST
  11. Morning Market Losers

    Benzinga | Oct. 4, 2013 | 10:06AM EST
  12. Benzinga's Top Pre-Market Losers

    Benzinga | Oct. 4, 2013 | 08:12AM EST
  13. Stocks To Watch For October 4, 2013

    Benzinga | Oct. 4, 2013 | 02:46AM EST
  14. NeoStem Prices 5M Share IPO at $7.00/Share

    Benzinga | Oct. 3, 2013 | 20:41PM EST
  15. UPDATE: NeoStem Announces Proposed Public Offering of Common Stock

    Benzinga | Oct. 3, 2013 | 16:03PM EST
  16. NeoStem Chair, CEO Smith Sends Letter to Holders: Says Co. On Track for Preserve Phase 2 Enrollment This Year

    Benzinga | Sep. 25, 2013 | 07:31AM EST
  17. NeoStem Reports Third-Data Safety Monitoring Board Review of PreSERVE AMI Trial

    Benzinga | Sep. 17, 2013 | 07:31AM EST
  18. NeoStem Reports Licensing of Treg Patents

    Benzinga | Sep. 16, 2013 | 07:35AM EST
  19. Neostem Issues Correction to Earlier Release: Said Phase 2 Trial Reference Should Have Been Related to Phase 2 SBIR Grant

    Benzinga | Sep. 13, 2013 | 15:39PM EST
  20. NeoStem's PCT Names Shaw VP of Commercial Sales, Hampson Senior Director of Engineering, Innovation

    Benzinga | Aug. 12, 2013 | 07:32AM EST
  21. NeoStem Announces Further Expansion of IP Coverage

    Benzinga | Jan. 22, 2013 | 00:32AM EST
  22. NeoStem's Progenitor Cell Therapy Enters Deal for Cell Therapy Manufacturing Services

    Benzinga | Jan. 16, 2013 | 01:08AM EST
  23. NeoStem Announces $1.2M NIH Grant Award for First Clinical Study of VSEL Technology in Humans

    Benzinga | Nov. 20, 2012 | 00:36AM EST
  24. Neostem Inc. Reports Operating Results (10-Q)

    GuruFocus | Nov. 13, 2012 | 11:06AM EST
  25. Benzinga's Microcap Movers for Wednesday September 5, 2012

    Benzinga | Sep. 5, 2012 | 12:53PM EST
  26. Neostem Inc. Reports Operating Results (10-Q)

    GuruFocus | Aug. 14, 2012 | 03:12AM EST
  27. HCA Holdings, American Capital Mortgage Investment Crp Among Stocks Down on High Volume Monday

    FoxBusiness | Aug. 6, 2012 | 06:32AM EST
  28. Conceptus, RTI International Metals Among Stocks Gapping Up Wednesday

    FoxBusiness | Aug. 1, 2012 | 04:31AM EST
  29. Arch Coal, NetSuite Among Stocks Gapping Up Friday

    FoxBusiness | Jul. 27, 2012 | 04:31AM EST
  30. NeoStem's Subsidiary, Progenitor Cell Therapy, and SOTIO Enter Into a Phase 3 Manufacturing Services Agreement

    Benzinga | Jul. 16, 2012 | 01:31AM EST
  31. Neostem Gapping Up Wednesday

    FoxBusiness | Jul. 11, 2012 | 04:30AM EST
  32. Benzinga's Microcap Movers for Monday July 9, 2012

    Benzinga | Jul. 9, 2012 | 11:42AM EST
  33. WellCare Health Plans, Molina Healthcare Among Stocks Gapping Up Monday

    FoxBusiness | Jul. 9, 2012 | 04:39AM EST
  34. Network Equipment Technologies, National Bank of Greece Among Stocks Gapping Up Tuesday

    FoxBusiness | Jun. 19, 2012 | 04:31AM EST
  35. Amorcyte, a NeoStem Company, Enrolls First Patient in PreSERVE Phase 2 Trial for Acute Myocardial Infarction

    Benzinga | Jan. 25, 2012 | 00:47AM EST
  36. Top Narrow Based Indexes For December 19

    Benzinga | Dec. 19, 2011 | 03:14AM EST
Trading Center